Reprodüktif Dönemde Endometrioma Yönetimi
Özet
Reprodüktif dönemde endometrioma yönetimi, hastanın semptomları, kist boyutu ve fertilite hedeflerine göre bireyselleştirilmelidir. Endometriomalar genellikle pelvik ağrı, dismenore ve infertilite gibi semptomlarla kendini gösterir. Tanı çoğunlukla transvajinal ultrasonografi (TVUS) ile konur. Küçük ve asemptomatik endometriomalar aktif izlem altında tutulabilir, bu yaklaşım özellikle fertilitenin korunması planlanan genç kadınlar için uygun bir seçenektir. Medikal tedavi, hormonal tedaviler ve nonsteroid antiinflamatuar ilaçlarla semptomların yönetilmesini hedefler; ancak bu yöntemler kistin tamamen iyileşmesini sağlamaz. Cerrahi tedavi, büyük kistlerin çıkarılması ve semptomların azaltılması için tercih edilir. Kistektomi, over fonksiyonunu koruma açısından ooforektomiye göre daha avantajlıdır, ancak rekürrens riski daha yüksektir. Cerrahi sonrası aktif izlem ve hormonal tedavi, rekürrens riskini azaltmak için önerilmektedir. Yönetim stratejileri, her hastanın bireysel durumu göz önünde bulundurularak belirlenmeli, özellikle fertilitenin korunması planlanan kadınlarda cerrahi müdahaleler dikkatle değerlendirilmelidir.
The management and treatment of endometrioma during the reproductive period should be individualized based on the patient's symptoms, cyst size, and fertility goals. Endometriomas commonly present with pelvic pain, dysmenorrhea, and infertility. Diagnosis is primarily made through transvaginal ultrasonography (TVUS). Small, asymptomatic endometriomas can be managed with active surveillance, a suitable approach particularly for young women with fertility plans. Medical treatment focuses on managing symptoms using hormonal therapies and nonsteroidal anti-inflammatory drugs; however, these methods do not completely resolve the cyst. Surgical treatment is preferred for the removal of large cysts and symptom relief. Cystectomy is more advantageous than oophorectomy in preserving ovarian function, but it carries a higher risk of recurrence. Postoperative hormonal therapy is recommended to reduce the risk of recurrence. Management strategies should be tailored to the individual patient's condition, with surgical interventions carefully evaluated, especially in women planning for future pregnancies.
Referanslar
Wentzensen, N., Poole, E. M., Trabert, B., et al. (2016). Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. Journal of Clinical Oncology, 34(24), 2888-2898.
Sarbazi, F., Akbari, E., Karimi, A., et al. (2021). The Clinical Outcome of Laparoscopic Surgery for Endometriosis on Pain, Ovarian Reserve, and Cancer Antigen 125 (CA-125): A Cohort Study. International Journal of Fertility & Sterility, 15(4), 275-282.
Bazot, M., Bharwani, N., Huchon, C., et al. (2017). European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Pelvic Endometriosis. European Radiology, 27(7), 2765-2775.
Timmerman, D., Van Calster, B., Testa, A., et al. (2016). Predicting the Risk of Malignancy in Adnexal Masses Based on the Simple Rules from the International Ovarian Tumor Analysis Group. American Journal of Obstetrics and Gynecology, 214(4), 424-437.
Friedrich, L., Meyer, R., Levin, G. (2021). Management of Adnexal Mass: A Comparison of Five National Guidelines. European Journal of Obstetrics & Gynecology and Reproductive Biology, 265, 80-86.
Vercellini, P., De Matteis, S., Somigliana, E., et al. (2013). Long-term Adjuvant Therapy for the Prevention of Postoperative Endometrioma Recurrence: A Systematic Review and Meta-Analysis. Acta Obstetricia et Gynecologica Scandinavica, 92(1), 8-15.
Chapron, C., Santulli, P., Bordonne, C., et al. (2018). The role of surgery in the management of endometrioma. Fertility and Sterility, 110(6), 1030-1032.
Ozkan, S., Arici, A., Duleba, A. J. (2019). Progestins for endometriosis: Treatment options and patient selection. Reproductive Biomedicine Online, 38(3), 291-298.
Vercellini, P., Vigano, P., Somigliana, E., et al. (2021). Endometriosis and infertility: treatment modalities and clinical outcomes. Best Practice & Research Clinical Obstetrics & Gynaecology, 27(2), 295-305.
Eisenberg, V. H., Weil, C., Meidan, R., et al. (2020). Gonadotropin-releasing hormone analogues in the treatment of endometriosis: A systematic review and meta-analysis. American Journal of Obstetrics and Gynecology, 222(3), 227-236.
Bedaiwy, M. A., et al. (2019). Role of aromatase inhibitors in the management of endometriosis: A systematic review and meta-analysis. Journal of Obstetrics and Gynaecology Research, 46(4), 655-666.
Eberle, A., Nguyen, D. B., Smith, J. P., et al. (2024). Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-Analysis. Obstetrics & Gynecology, 143(1), 53-63.
Chiu, C. C., Hsu, T. F., Jiang, L. Y., et al. (2022). Maintenance Therapy for Preventing Endometrioma Recurrence After Endometriosis Resection Surgery - A Systematic Review and Network Meta-Analysis. Journal of Minimally Invasive Gynecology, 29(4), 602-614.
Cohen, A., Almog, B., Tulandi, T. (2017). Sclerotherapy in the Management of Ovarian Endometrioma: Systematic Review and Meta-Analysis. Fertility and Sterility, 108(1), 117-128.
Zupi, E., Centini, G., Lazzeri, L., et al. (2014). Endometrioma Recurrence after Ultraminimal Invasive Laparoscopic Excision: Predictive Factors. Journal of Minimally Invasive Gynecology, 21(3), 457-462.
Garcia-Velasco, J. A., Somigliana, E., Landi, S., et al. (2023). Impact of Endometrioma Surgery on Ovarian Reserve and Pregnancy Outcomes: A Systematic Review. Human Reproduction Update, 29(2), 184-196.
Somigliana, E., Infantino, M., Benaglia, L., et al. (2022). Ovarian Endometrioma: Reoperation and Its Effect on Ovarian Reserve and Pregnancy Rate. Journal of Minimally Invasive Gynecology, 29(1), 92-100.
Ferrero, S., Bentivoglio, G., Remorgida, V., et al. (2023). Endometrioma and Infertility: Surgical Treatment and Reproductive Outcomes. Current Opinion in Obstetrics and Gynecology, 35(2), 90-97.
Bourdon, M., Santulli, P., Maignien, C., et al. (2023). Reproductive Outcomes After Endometrioma Surgery: The Role of Assisted Reproductive Techniques. Reproductive BioMedicine Online, 46(1), 43-50.
